For every tomorrow
Developing non-invasive therapies for Glioblastoma
An interview on GlobalData Healthcare with Annabel Kartel-Allen.
Richard talks GBM, Sonodynamic Therapy and CureGBM's proposed trials
Richard (with his sister Jane) founded CureGBM after losing their dad to glioblastoma in 2021 –
about two months after his diagnosis.
"GBM treatment isn't good enough, and that's not fair."
Richard sat down with Annabel Kartal-Allen from GlobalData Healthcare podcast to discuss GBM, SDT, and trials…
His vision is one day:
SDT could be an outpatient treatment, delivered alongside routine scans – and made accessible to all who might need it.
Healthcare centres around the world could offer this to patients on the day a brain tumour is first diagnosed.
Simply put GBM treatment hasn’t changed in about 20 years. SDT challenges the status-quo of brain tumour treatment, potentially bringing a new pathway of hope for patients and families. Cure GBM’s planned trials could usher in a new treatment method.
Thank you to Annabel Kartal-Allen from GlobalData Healthcare for the interview and offering this platform to CureGBM.
More Patient Stories
Discover real patient journeys with Sonodynamic Therapy (SDT) and how innovation, courage and care are redefining what’s possible for tomorrow.
For every tomorrow
If this episode resonates with you, please share it. The more voices we amplify, the more awareness we create.
Help us bring awareness to the urgent need for better brain tumour treatments and faster access to breakthrough therapies.